Whole Body Hyperthermia: A Phase-l Trial of a Potential Adjuvant to Chemotherapy

Fourteen patients with a variety of neoplasms not responsive to standard forms of therapy underwent whole body hyperthermia for a maximum 4 h at 41.8 degrees C. This was a phase-I cancer trial designed to develop whole body hyperthermia as an adjuvant to systemic chemotherapy. Intravenous analgesia was used to sedate patients, obviating the need for general endotracheal anesthesia. Hyperthermia was induced by means of a high-flow water perfusion suit. Cardiovascular performance was evaluated using a flow-directed pulmonary artery catheter. Patients developed a twofold mean increase in cardiac index without evidence of cardiac damage by ECG or creatine phosphokinase (CPK) isoenzymes. An acute fall in serum magnesium and phosphate and an acute rise in arterial pH, serum CPK values, and granulocyte count occurred in all patients. There were no clotting abnormalities. Toxicity included fatigue, diarrhea, nausea, and transient elevations in liver enzymes. Four patients were febrile for 36 h after initial defervescence. Peripheral neuropathy developed in four. These results show that with carefully monitored conditions whole body hyperthermia is feasible.

[1]  A. Quick.  On the quantitative estimation of prothrombin. , 1945, American journal of clinical pathology.

[2]  D. Karnofsky,et al.  The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .

[3]  O. Ratnoff,et al.  A new method for the determination of fibrinogen in small samples of plasma. , 1951, The Journal of laboratory and clinical medicine.

[4]  K. Brinkhous,et al.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. , 1953, The Journal of laboratory and clinical medicine.

[5]  J. Feinberg.  A New Quantitative Method for Antigen–Antibody Titrations in Gels , 1956, Nature.

[6]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .

[7]  A. Fletcher,et al.  The mechanism of clot dissolution by plasmin. , 1959, The Journal of clinical investigation.

[8]  F. McDowell,et al.  THE EFFECTS OF INDUCED HYPERTHERMIA ON PATIENTS WITH MULTIPLE SCLEROSIS* , 1959, Journal of neurology, neurosurgery, and psychiatry.

[9]  J. Peden,et al.  Use of the plasma thrombin time to assess the adequacy of in vivo neutralization of heparin: comparative studies following operations employing extracorporeal circulation. , 1959, Blood.

[10]  C. Heidelberger,et al.  Selective heat sensitivity of cancer cells. Biochemical and clinical studies , 1967 .

[11]  C. Abildgaard,et al.  A semiautomatic one-stage factor 8 assay with a commercially prepared standard. , 1967, The Journal of laboratory and clinical medicine.

[12]  A. Zipursky,et al.  A microhemagglutination-inhibition assay for the quantitation of fibrinogen breakdown products. , 1968, The Journal of laboratory and clinical medicine.

[13]  C. Heidelberger,et al.  Effects of elevated temperatures and drugs on the viability of L1210 leukemia cells. , 1970, Cancer research.

[14]  S E Silvis,et al.  Paresthesias, weakness, seizures, and hypophosphatemia in patients receiving hyperalimentation. , 1972, Gastroenterology.

[15]  J. Overgaard,et al.  Investigations on the possibility of a thermic tumour therapy. I. Short-wave treatment of a transplanted isologous mouse mammary carcinoma. , 1972, European journal of cancer.

[16]  Douglas A. Wolfe,et al.  Nonparametric Statistical Methods , 1973 .

[17]  C. Heidelberger,et al.  Studies on the quantitative biology of hyperthermic killing of HeLa cells. , 1973, Cancer research.

[18]  A. Smith,et al.  Circulatory and biochemical effects of whole body hyperthermia , 1974, The British journal of surgery.

[19]  A. Smith,et al.  Clinical Effects of Whole-body Hyperthermia in Advanced Malignancy , 1974, British medical journal.

[20]  R. Weisel,et al.  Measurement of Cardiac Output by Thermodilution , 1975 .

[21]  B. Giovanella,et al.  Results of hyperthermic perfusion for melanoma of the extremities. , 1975, Surgery, gynecology & obstetrics.

[22]  G. Hahn,et al.  Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Giovanella,et al.  Selective lethal effect of supranormal temperatures on human neoplastic cells. , 1976, Cancer research.

[24]  M. Ravid,et al.  Proximal myopathy caused by latrogenic phosphate depletion. , 1976, JAMA.

[25]  S. Shibolet,et al.  Heat stroke: a review. , 1976, Aviation, space, and environmental medicine.

[26]  G. Hahn,et al.  Tumor cure and cell survival after localized radiofrequency heating. , 1977, Cancer research.

[27]  Symptomatic magnesium deficiency after small-intestinal bypass for obesity. , 1977, British medical journal.

[28]  J. Larkin,et al.  Systemic thermotherapy: Description of a method and physiologic tolerance in clinical subjects , 1977, Cancer.

[29]  V. Oliverio,et al.  Clinical pharmacology of anticancer drugs. , 1977, Seminars in oncology.